<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sargent JD</submitter><funding>NIDA NIH HHS</funding><funding>U.S. Department of Health and Human Services</funding><funding>National Institutes of Health</funding><funding>Center for Tobacco Products, Food and Drug Administration</funding><funding>National Institute on Drug Abuse</funding><funding>NIH HHS</funding><pagination>1607-1618</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9575972</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(10)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>We examined the relationship between current tobacco use and functionally important respiratory symptoms.&lt;h4>Methods&lt;/h4>Longitudinal cohort study of 16 295 US adults without COPD in Waves 2-3 (W2-3, 2014-2016) of the Population Assessment of Tobacco and Health Study. Exposure-Ten mutually exclusive categories of tobacco use including single product, multiple product, former, and never use (reference). Outcome-Seven questions assessing wheezing/cough were summed to create a respiratory symptom index; cutoffs of ≥2 and ≥3 were associated with functional limitations and poorer health. Multivariable regressions examined both cutoffs cross-sectionally and change over approximately 12 months, adjusting for confounders.&lt;h4>Results&lt;/h4>All tobacco use categories featuring cig</pubmed_abstract><journal>Nicotine &amp; tobacco research : official journal of the Society for Research on Nicotine and Tobacco</journal><pubmed_title>Tobacco Use and Respiratory Symptoms Among Adults: Findings From the Longitudinal Population Assessment of Tobacco and Health (PATH) Study 2014-2016.</pubmed_title><pmcid>PMC9575972</pmcid><funding_grant_id>HHSN271201100027C</funding_grant_id><pubmed_authors>Hyland A</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Borek N</pubmed_authors><pubmed_authors>Pierce JP</pubmed_authors><pubmed_authors>Anic G</pubmed_authors><pubmed_authors>Niaura R</pubmed_authors><pubmed_authors>Taylor KA</pubmed_authors><pubmed_authors>Brunette M</pubmed_authors><pubmed_authors>Schwartz L</pubmed_authors><pubmed_authors>Edwards KC</pubmed_authors><pubmed_authors>Cummings KM</pubmed_authors><pubmed_authors>Thekkudan T</pubmed_authors><pubmed_authors>Kimmel HL</pubmed_authors><pubmed_authors>Sargent JD</pubmed_authors><pubmed_authors>Gardner LD</pubmed_authors><pubmed_authors>Woloshin S</pubmed_authors><pubmed_authors>Goniewicz ML</pubmed_authors><pubmed_authors>Callahan-Lyon P</pubmed_authors><pubmed_authors>Tanski S</pubmed_authors><pubmed_authors>Halenar MJ</pubmed_authors><pubmed_authors>Emond J</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tobacco Use and Respiratory Symptoms Among Adults: Findings From the Longitudinal Population Assessment of Tobacco and Health (PATH) Study 2014-2016.</name><description>&lt;h4>Introduction&lt;/h4>We examined the relationship between current tobacco use and functionally important respiratory symptoms.&lt;h4>Methods&lt;/h4>Longitudinal cohort study of 16 295 US adults without COPD in Waves 2-3 (W2-3, 2014-2016) of the Population Assessment of Tobacco and Health Study. Exposure-Ten mutually exclusive categories of tobacco use including single product, multiple product, former, and never use (reference). Outcome-Seven questions assessing wheezing/cough were summed to create a respiratory symptom index; cutoffs of ≥2 and ≥3 were associated with functional limitations and poorer health. Multivariable regressions examined both cutoffs cross-sectionally and change over approximately 12 months, adjusting for confounders.&lt;h4>Results&lt;/h4>All tobacco use categories featuring cig</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T07:26:49.431Z</modification><creation>2025-04-04T07:26:49.431Z</creation></dates><accession>S-EPMC9575972</accession><cross_references><pubmed>35366322</pubmed><doi>10.1093/ntr/ntac080</doi></cross_references></HashMap>